Out of stock
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this
Tynifer
Incepta Pharmaceuticals Ltd.
Generic: Ferric Maltol
Medicine Overview of Tynifer 30mg capsule
বাংলা
English
Indication
Iron Deficiency Anemia
Administration
Take 1 hr before or 2 hr after a meal
Adult Dose
Iron Deficiency An iron replacement product indicated for iron deficiency 30 mg PO BID Continue as long as necessary until ferritin levels are within the normal range Treatment duration depends on severity of iron deficiency but generally at least 12 weeks of treatment is required
Contraindication
Hypersensitivity to active substance or to any of the excipients Hemochromatosis and other iron overload syndromes Patients receiving repeated blood transfusions
Mode of Action
Nonsalt, oral formulation of ferric iron Supplements iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Delivers iron for uptake across the intestinal wall and transfer to transferrin and ferritin
Precaution
Avoid use in patients with an active inflammatory bowel disease flare, as there is potential risk of increased inflammation in the gastrointestinal tract Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children ages ≤6 years; keep this product out of reach of children Iron overload Excessive therapy with iron products can lead to excess storage of iron with the possibility of iatrogenic hemosiderosis; do not administer to patients with evidence of iron overload or patients receiving IV iron Assess iron parameters before initiating treatment and monitor during therapy
Side Effect
1-10% Flatulence (4.6%) Diarrhea (4%) Constipation (4%) Discolored feces (4%) Abdominal pain (2.9%) Nausea (1.7%) Vomiting (1.7%) Abdominal pain (1.7%) Abdominal discomfort (1.1%) Abdominal distension (1.1%)
Pregnancy Category Note
Pregnancy Not absorbed systemically as an intact complex following oral administration Maternal use is not expected to result in fetal exposure to the drug Animal data In animal reproduction studies, oral administration of ferric or ferrous compounds to gravid CD1-mice and Wistar rats during organogenesis at doses 13-32 times the recommended human dose resulted in no adverse developmental outcomes Overdose of iron in pregnant women may carry a risk for spontaneous abortion, gestational diabetes, and fetal malformation Clinical considerations Untreated iron deficiency anemia (IDA) in pregnancy is associated with adverse maternal outcomes such as postpartum anemia Adverse pregnancy outcomes associated...
... Show moreInteraction
There are no empirical data on avoiding drug interactions between ferric maltol and concomitant oral medication Concomitant use of some oral drugs may reduce bioavailability of iron after ferric maltol administration Separate the administration of ferric maltol from these drugs; duration of separation may depend on the absorption characteristics of the medication concomitantly administered, such as time to peak concentration or whether the drug is an immediate- or extended-release product; monitor clinical response to ferric maltol Coadministration of ferric maltol with some oral medications may also decrease the bioavailability of some drugs For oral drugs for which reductions in bioavailability...
... Show more Brief Description
Indications
Ferric Maltol capsule is indicated for the treatment of iron deficiency in adults.
Pharmacology
Ferric Maltol delivers iron for uptake across the intestinal wall and transfer to transferrin and ferritin. It has been shown to increase serum iron parameters, including ferritin and transferrin saturation (TSAT)
Dosage & Administration
Ferric Maltol capsule should be taken in oral route, preferably on an empty stomach, at least 1 hour before or 2 hours after meals. Do not open, break or chew Ferric Maltol capsule. The recommended dosage of Ferric Maltol is 30 mg twice daily. Treatment duration will depend on the severity of iron deficiency but generally at least 12 weeks of treatment is required. The treatment should be continued as long as necessary until ferritin levels are within the normal range.Use in children and adolescents: Safety and effectiveness of ferric maltol have not been established in pediatric patients.
Interaction
Drug interaction with medication: Concomitant use of iron products with dimercaprol may increase the risk of nephrotoxicity. Avoid concomitant use of ferric maltol with dimercaprol. Concomitant use of ferric maltol may decrease the bioavailability of some drugs, including mycophenolate, ethynyl estradiol, ciprofloxacin and doxycycline. For oral drugs where reductions in bioavailability may cause clinically significant effects on its safety or efficacy, separate the administration of ferric maltol by at least 4 hours.Drug interaction with food and others: Food has been shown to decrease the bioavailability of iron after administration of ferric maltol.
Contraindications
Ferric maltol is contraindicated in patients with known hypersensitivity to ferric maltol or any other components of this product. It is also contraindicated in patients with a history of hemochromatosis and other iron overload syndromes and in patients receiving repeated blood transfusions.
Side Effects
The most common side effects are flatulence, diarrhea, constipation, feces discolored, abdominal pain, nausea and vomiting.
Pregnancy & Lactation
Ferric maltol is not absorbed systemically as an intact complex following oral administration and maternal use is not expected to result in fetal exposure to the drug. There are no data on the presence of ferric maltol in human milk, the effects on the breastfed child or the effects on milk production. Ferric maltol is not absorbed systemically as an intact complex by the mother following oral administration and breastfeeding is not expected to result in exposure of the child to ferric maltol.
Precautions & Warnings
Avoid use of ferric maltol in patients with an active inflammatory bowel disease (IBD) flare, as there is potential risk of increased inflammation in the gastrointestinal tract. Do not administer to patients with evidence of iron overload or patients receiving intravenous iron. Assess iron parameters prior to initiating ferric maltol and monitor iron parameters while on therapy. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. In case of accidental overdose, patient should be treated immediately.
Overdose Effects
No data is available regarding overdose of ferric maltol in patients. Early signs and symptoms of iron overdose may include nausea, vomiting, abdominal pain and diarrhea. In more serious cases there may be evidence of hypoperfusion, metabolic acidosis and systemic toxicity. Dosages of ferric maltol in excess of iron needs may lead to accumulation of iron in storage sites leading to hemosiderosis.
Therapeutic Class
Oral Iron preparations
Storage Conditions
Store in a cool (below 25°C) and dry place protected from light. Keep away from the reach of children.
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
